MEMBRANE SIALOGLYCOLIPIDS REGULATE THE ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY BY LIPOSOMES CONTAINING TRINITROPHENYLAMINOCAPROYLDIPALMITOYLPHOSPHATIDYLETHANOLAMINE
- 1 January 1983
- journal article
- research article
- Vol. 48 (1) , 129-140
Abstract
Liposomes associated with trinitrophenylaminocaproyldipalmitoylphosphatidylethanolamine (TNP-Cap-DPPE) activated the alternative complement pathway (ACP) of the guinea pig. The complement-activating capacity (CAC) of liposomes with TNP-Cap-DPPE (TNP-Cap-liposomes) was inhibited by the insertion of sialoglycolipids, such as GM3, onto the membrane. Neutral glycolipids tested had no inhibitory effect on the CAC of the TNP-Cap-liposomes. The minimum amount of sialoglycolipids required for the inhibition of the ACP-activating capacity of TNP-Cap-liposomes was .ltoreq. 0.01 in molar ratio to dimyristoylphosphatidylcholine in the liposomes. Since the insertion of charged amphiphiles did not affect the status of TNP-Cap-liposomes containing glycolipids with respect to their ACP-activating capacity, the surface potential caused by sialoglycolipids was disregarded as being the factor responsible for restriction of the complement-activating effect. For the inhibitory effect to be manifested, the presence of GM3 was required on the same liposome membrane where the TNP-Cap-triggered ACP activation was taking place. Thus, sialoglycolipids may inhibit ACP activation by reacting directly on certain nascently activated complement proteins. Insertion of GM3 could not inhibit liposome lysis via the classical complement pathway. The presence of antibody reaction significantly reduced the inhibitory capacity of GM3, indicating that natural antibody may be responsible for discriminating between self and heterologous surfaces, thus cancelling the glycolipid-mediated restriction of ACP activation in the case of heterologous cell surface, bringing about lysis by the cancellation of the glycolipid-mediated restriction of ACP activation on heterologous cell surfaces.This publication has 24 references indexed in Scilit:
- Gangliosides of human meconium ‐ detection of a possible fetal antigenFEBS Letters, 1981
- A simple method to measure anti-glycolipid antibody by using complement-mediated immune lysis of fluorescent dye-trapped liposomesJournal of Immunological Methods, 1981
- A glycolipid on the surface of mouse natural killer cellsEuropean Journal of Immunology, 1980
- Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathwayProceedings of the National Academy of Sciences, 1978
- Blood group i and I activities of “lacto-N-norhexaosylceramide” and its analogues: The structural requirements for i-specificitiesBiochemical and Biophysical Research Communications, 1978
- Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteinsThe Journal of Experimental Medicine, 1977
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Control of the amplification convertase of complement by the plasma protein beta1H.Proceedings of the National Academy of Sciences, 1976
- GANGLIOSIDES OF HUMAN MYELIN: SIALOSYLGALACTOSYLCERAMIDE (G7) AS A MAJOR COMPONENTJournal of Neurochemistry, 1973
- Properdin System and Immunity: II. Interaction of the Properdin System with PolysaccharidesScience, 1955